Ikoma, Japan

Masashi Niwa

This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 2006-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masashi Niwa. Retrieved from https://idiyas.com/inventor/masashi-niwa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Osaka, JP (2006 - 2008)
  • Ikoma, JP (2015 - 2018)

Company Filing History:


Years Active: 2006-2018

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Masashi Niwa: Innovator in Pharmaceutical Development

Introduction

Masashi Niwa is a prominent inventor based in Ikoma, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of complex compounds. With a total of 6 patents to his name, Niwa's work focuses on improving the stability and efficacy of medicinal compounds.

Latest Patents

Niwa's latest patents include the development of 2-[[[2-[(Hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate. This compound, referred to as compound A, addresses several challenges in pharmaceutical formulation. The issues include difficulties in recrystallization, varying storage stability depending on the salt type, and the risk of mineral deposition in the stomach upon repeated oral administration. Niwa's research led to the discovery that the benzenesulfonate form of compound A exhibits excellent stability under various conditions and does not decompose easily. Furthermore, he developed methods to selectively produce two crystal forms of this compound, ensuring no mineral deposition occurs even after extended use.

Career Highlights

Niwa has dedicated his career to advancing pharmaceutical science. His innovative approaches have not only improved the stability of complex compounds but have also enhanced their safety profiles. His work is recognized within the industry, contributing to the reputation of Santen Pharmaceutical Co., Ltd., where he is employed.

Collaborations

Throughout his career, Niwa has collaborated with notable colleagues, including Hiroshi Deguchi and Maki Tokai. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Masashi Niwa's contributions to pharmaceutical development exemplify the impact of innovative thinking in medicine. His work continues to influence the field, ensuring safer and more effective treatments for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…